Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Circulating lnc-LOC as a novel noninvasive biomarker in the treatment surveillance of acute promyelocytic leukaemia

Fig. 1

BM lnc-LOC expression and diagnostic value in APL patients. a Comparison of BM lnc-LOC expression in different groups, including APL, non-APL AML and healthy donors. b ROC curve analysis of BM lnc-LOC expression for the discrimination of APL from healthy donors. c ROC curve analysis of lnc-LOC expression for the discrimination of APL from non-APL AML. d ROC curve analysis of lnc-LOC expression for the discrimination of non-APL AML from healthy donors. * Statistically significant

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us